As increased marijuana legalization permits expansion into recreational and medical spaces, the two segments are anticipated to separate as companies within either, or both, of the two industries implement different strategies to target their consumers. Analyst firm Jefferies’ current models of the global medical market stand at $8 billion for this year and then rising to $19 billion by 2029. The firm also forecasts the recreational market at $9 billion for 2019 and then amounting to $31 billion by 2029. “Medical and [recreational] are broadly similar now but will become two distinct segments. Rec. will be about creating brands and delivering differentiating experiences, while medical will be about developing unique and specific drug formulations, with exacting pharma ingredients, protected by IP” according to Jefferies’ analyst Owen Bennett. Jefferies is the latest of the Wall Street firms to add marijuana to their coverage, following the likes of Cowen and Piper Jaffray whom already cover the budding industry. With that being said, it may be wise for investors to also keep tabs on the nascent industry and marijuana stocks3 Marijuana Stocks To Add To Your Watch-List